Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer

Nature Medicine

Volumn 4, Issue 1, 1998, Pages 58-64

  Bunting, Kevin D ^a   Sangster, Mark Y ^a   Ihle, James N ^a   Sorrentino, Brian P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; ENZYME DEFICIENCY; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC STEM CELL; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION;

AGAMMAGLOBULINEMIA; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; JANUS KINASE 3; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, SCID; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; T-LYMPHOCYTES;

EID: 0031890632     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0198-058     Document Type: Article

References (34)

1. Hirschhorn, R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr. Res. 33, S35-S41 (1993).
2. Noguchi, M. et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147 (1993).
3. Macchi, P. et al. Mutations of Jak-3 gene in patients with autosomal severe combined immunodeficiency (SCID). Nature 377, 65-68 (1995).
4. Russell, S. et al. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 270, 797-800 (1995).
5. Buckley, R. et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin. Hematol. 30, 92-104 (1993).
6. Dror, Y. et al. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81, 2021-2030 (1993).
7. van Leeuwen, J. et al. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency, Blood 84, 3936-3947 (1994).
8. Blaese, R. et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480 (1995).
9. Bordignon, C. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475 (1995).
10. Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2, 223-238 (1995).
11. Johnston, J. et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370, 151-153 (1994).
12. Witthuhn, B. et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370, 153-157 (1994).
13. Park, S. et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3, 771-782 (1995).
14. Nosaka, T. et al. Defective lymphoid development in mice lacking Jak3. Science 270, 800-802 (1995).
15. Thomis, D., Gurniak, C., Tivol, E., Sharpe, A. & Berg, L. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797 (1995).
16. Candotti, F. et al. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood 87, 3097-3102 (1996).
17. Taylor, N. et al. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the γ⊂ gene. Blood 87, 3103-3107 (1996).
18. Candotti, F. et al. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J. Exp. Med. 183, 2687-2692 (1996).
19. Allay, J., Dumenco, L., Koc, O., Liu, L & Gerson, S. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells, Blood 85, 3342-3351 (1995).
20. Laker, C. et al. Autocrine stimulation after transfer of the granu locyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc. Natl. Acad. Sci. USA 84, 8458-8462 (1987).
21. Spencer, H., Sleep, S., Rehg, J., Blakley, R. & Sorrentino, B. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87, 2579-2587 (1996).
22. Buckley, R. et al. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants. J. Pediatr. 130, 378-387 (1997).
23. Orkin, S. & Motulsky, A. (study panel chairs). Report and recommendations of the panel to assess the NIH investment in research on gene therapy, (http;// www.nih.gov/news/panelrep.html), access date 5/20/97.
24. phox-deficient model of chronic granulomatous disease. Blood 89, 2268-2275 (1997).
25. Hirschhorn, R. et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nature Genet. 13, 290-295 (1996).
26. Stephan, V. et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335, 1563-1567 (1996).
27. Luo, H. et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-STAT pathways. Mol. Cell. Biol. 17, 1562-1571 (1997).
28. Luo, H., Hanratty, W. & Dearolf, C. An amino acid substitution in the Drosophila hop Tum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14, 1412-1420 (1995).
29. Smith, M., Duhe, R., Liu, Y. & Farrar W. Microinjected cDNA encoding JAK2 protein-tyrosine kinase induces DMA synthesis in NIH 3T3 cells. FEBS Lett. 408, 327-330 (1997).
30. Miller, A. & Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902 (1986).
31. Markowitz, D., Goff, S. & Bank, A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124 (1988).
32. Bodine, D., McDonagh, K., Seidel, N. & Nienhuis, A. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp. Hematol. 19, 206-212 (1991).
33. Bodine, D., Karlsson, S. & Nienhuis, A. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 86, 8897-8901 (1989).
34. Sorrentino, B. et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103 (1992).